Antiplatelets, Anticoagulants, And Fibrinolytics

Approved & Edited by ProProfs Editorial Team
The editorial team at ProProfs Quizzes consists of a select group of subject experts, trivia writers, and quiz masters who have authored over 10,000 quizzes taken by more than 100 million users. This team includes our in-house seasoned quiz moderators and subject matter experts. Our editorial experts, spread across the world, are rigorously trained using our comprehensive guidelines to ensure that you receive the highest quality quizzes.
Learn about Our Editorial Process
| By NeilTurco
N
NeilTurco
Community Contributor
Quizzes Created: 3 | Total Attempts: 11,084
Questions: 30 | Attempts: 1,151

SettingsSettingsSettings
Drug Quizzes & Trivia

Through several mechanisms of action, these agents are used to achieve the fine balance between clotting and systemic bleeding. These drugs are very common, so you should become an expert on every detail regarding them. Test your wit with various forms of questions and see if you have what it takes to be a pharmacist!


Questions and Answers
  • 1. 

    What is the average lifespan of a platelet?

    • A.

      1 day

    • B.

      2-5 days

    • C.

      5-10 days

    • D.

      90 days

    Correct Answer
    C. 5-10 days
    Explanation
    The answer is 5-10 days for the lifespan of platelets. This has implications for the use of irreversible anti platelet medications, which will have effects even when discontinued due to the time necessary for platelet regeneration. A normal platelet count is 150,000 to 400,000 per microLiter, which can be abbreviated as "150" to "400." Platelets are normally smooth, but have glycoproteins that can assist in the aggregation and formation of a clot.

    Rate this question:

  • 2. 

    Is Ticagrelor (Brilinta) reversible?

    • A.

      Yes

    • B.

      No

    Correct Answer
    A. Yes
    Explanation
    Ticagrelor is unique among the antiplatelets in that it is reversible. It is also a non-thienopyridine, and must be used with low-dose aspirin.

    Rate this question:

  • 3. 

    Which of the following is NOT an indication of aspirin?

    • A.

      Primary prophylaxis

    • B.

      Secondary prophylaxis

    • C.

      Treatment of acute coronary syndromes

    • D.

      Treatment of acute ischemic stroke

    • E.

      Treatment of peripheral arterial disease

    • F.

      All of the above are indications of aspirin

    Correct Answer
    F. All of the above are indications of aspirin
    Explanation
    Please note that aspirin can be used for primary prophylaxis in appropriate individuals.

    Rate this question:

  • 4. 

    Clopidogrel (Plavix) has interactions primarily with which of the following CYP isozymes?

    • A.

      CYP 3A4 inhibitors

    • B.

      CYP 2D6 inhibitors

    • C.

      CYP 2E1 inhibitors

    • D.

      CYP 2C19 inhibitors

    Correct Answer
    D. CYP 2C19 inhibitors
    Explanation
    The inhibition of CYP 2C19 by drugs such as omeprazole, a PPI (proton pump inhibitor), will lead to less conversion of clopidogrel (a prodrug) to its active metabolite, and less antiplatelet activity. If a PPI is required, pantoprazole is the drug of choice due to less inhibition of CYP 2C19.

    Rate this question:

  • 5. 

    Ticagrelor (Brilinta) has interactions primarily with which CYP isozyme?

    • A.

      CYP 3A4 inhibitors

    • B.

      CYP 3A4 inducers

    • C.

      CYP 2C19 inhibitors

    • D.

      CYP 2D6 inhibitors

    • E.

      A and B

    Correct Answer
    E. A and B
    Explanation
    Ticagrelor has interactions with both CYP 3A4 inhibitors and inducers; thus, it may have several clinically significant drug-drug interactions. As a result, the maximum doses of simvastatin and lovastatin are 40 mg to prevent the incidence of rhabdomyolysis.

    Rate this question:

  • 6. 

    Which of the following are indications of cilostazol (Pletal)? Check all that apply.

    • A.

      Secondary prophylaxis

    • B.

      Intermittent claudication (peripheral arterial disease)

    • C.

      Invasive management of PCI

    • D.

      Stroke prevention

    Correct Answer
    B. Intermittent claudication (peripHeral arterial disease)
    Explanation
    Cilostazol (Pletal) has a unique niche in being useful for the treatment of intermittent claudication symptoms due to peripheral arterial disease (PAD). This is its only FDA-labeled indication. Of note, avoid cilostazol in heart failure patients.

    Rate this question:

  • 7. 

    Which of the following are indications of aspirin/dipyridamole (Aggrenox)? Check all that apply

    • A.

      Secondary MI prophylaxis

    • B.

      Fibrinolysis

    • C.

      Recurrent stroke prophylaxis

    • D.

      Primary MI prophylaxis

    Correct Answer
    C. Recurrent stroke propHylaxis
    Explanation
    This is a niche role for aspirin/dipyridamole (Aggrenox) and its only FDA-labeled indication.

    Rate this question:

  • 8. 

    What are glycoprotein IIb/IIIa inhibitors used for?

    • A.

      Invasive management during a PCI

    • B.

      Treatment of heart failure

    • C.

      Chronic prevention of blood clots

    • D.

      Coating of invasive lines

    Correct Answer
    A. Invasive management during a PCI
    Explanation
    By inhibiting the final common pathway for platelet aggregation at greater than 80% of receptor occupancy, these extremely potent agents are used during a PCI to prevent clotting. Basically, the platelets cannot hold hands and form the clot, so the patient is spared further clotting.

    Rate this question:

  • 9. 

    Which of the following glycoprotein IIb/III inhibitors are reversible? Check all that may apply.

    • A.

      Abciximab (Reopro)

    • B.

      Eptifibatide (Integrilin)

    • C.

      Tirofiban (Aggrastat)

    Correct Answer
    A. Abciximab (Reopro)
    Explanation
    The gold standard of glycoprotein IIb/IIIa inhibitors, abciximab (Reopro) is reversible by overwhelming the agent with platelets. The other agents (eptifibatide and tirofiban) are not reversible, have renal dosing, and are shorter-acting.

    Rate this question:

  • 10. 

    Which enzyme does warfarin act upon to exert its pharmacological effect?

    Correct Answer
    Vitamin K Oxide Reductase
    VKORC1
    Explanation
    Warfarin inhibits the enzyme "Vitamin K Oxide Reductase", which normally takes oxidized Vitamin K and reduces it in order for the reduced form to assist in the conversion of a prothrombin precursor to prothrombin. Less prothrombin means less thrombin, and less thrombin means less conversion of fibrinogen to fibrin. Warfarin inhibits the synthesis of the vitamin K dependent clotting factors (2, 7, 9, 10) and the ANTICOAGULANT proteins C and S. Since the anticoagulant proteins are inhibited first (shortest half lives), starting warfarin without a heparin or LMWH bridge can INCREASE the risk of clotting.

    Rate this question:

  • 11. 

    Warfarin is bound to which plasma protein?

    • A.

      Albumin

    • B.

      Alpha-1 acid glycoprotein

    • C.

      Hemoglobin

    Correct Answer
    A. Albumin
    Explanation
    Acidic and neutral drugs bind to albumin, which is basic. Basic drugs bind to alpha-1 acid glycoprotein. Oxygen binds to hemoglobin. Warfarin binds to albumin at greater than 95%. These are facts. Thus, if a patient has another drug on board that displaces warfarin from albumin, there will be more free warfarin and more anticoagulation. Something to consider.

    Rate this question:

  • 12. 

    Which of the following can affect the INR for a patient on warfarin? Check all that apply.

    • A.

      Demographics

    • B.

      Vitamin K intake

    • C.

      Hepatic function

    • D.

      Drug interactions

    Correct Answer(s)
    A. DemograpHics
    B. Vitamin K intake
    C. Hepatic function
    D. Drug interactions
    Explanation
    With vitamin K intake, always educate your patients to maintain a CONSISTENT intake of vitamin K. More vitamin K will lead to more clotting, but the patient can still eat their leafy green vegetables, since their increased intake was factored into their maintenance dosing.

    Rate this question:

  • 13. 

    For which indications should the goal INR be 2.0-3.0?

    • A.

      Prophylaxis of VTE

    • B.

      Treatment of VTE (DVT/PE)

    • C.

      Prophylaxis of stroke/systemic embolism

    • D.

      Mechanical aortic valve

    • E.

      Mechanical mitral valve

    • F.

      Bioprosthetic aortic valve

    • G.

      Bioprosthetic mitral valve

    Correct Answer(s)
    A. PropHylaxis of VTE
    B. Treatment of VTE (DVT/PE)
    C. PropHylaxis of stroke/systemic embolism
    D. Mechanical aortic valve
    F. Bioprosthetic aortic valve
    G. Bioprosthetic mitral valve
    Explanation
    Mechanical valves have greater risks of developing clots, and mitral valves have greater risks of clots due to the lower pressure compared to in the aorta. Therefore, the mechanical mitral valve requires a goal of 2.5-3.5. If a patient has both mechanical mitral and aortic valves, use the goal of 2.5-3.5.

    Rate this question:

  • 14. 

    The heparin or LMWH bridge with warfarin should be continued until the INR is greater than 2.0 for how many consecutive days?

    Correct Answer(s)
    2
    two
    Explanation
    The heparin/LMWH bridge is necessary due to the depletion of proteins C and S, which are anticoagulant proteins, before the other Vitamin K dependent clotting factors (2, 7, 9, 10). Thus, warfarin without the bridge could lead to a clot with initial therapy.

    Rate this question:

  • 15. 

    True or False: Unfractionated heparin can dissolve clots

    • A.

      True

    • B.

      False

    Correct Answer
    B. False
    Explanation
    Heparin can only prevent further clotting; it cannot dissolve a clot. You will need a clot-buster, aka a fibrinolytic such as tPA (alteplase/Activase) to break up an active clot. This is due to heparin's mechanism of action, which has an indirect effect on thrombin via antithrombin; thrombin eventually converts fibrinogen to fibrin, which solidifies a clot. By stopping thrombin, you can stop more fibrin from solidifying the clot, but heparin cannot get into and bust up a clot.

    Rate this question:

  • 16. 

    Check all of the advantages of direct thrombin inhibitors.

    • A.

      Do not require cofactor (antithrombin)

    • B.

      Bind clot-bound thrombin

    • C.

      Predictable effects of anticoagulation

    • D.

      Decreased bleeding compared to heparin

    Correct Answer(s)
    A. Do not require cofactor (antithrombin)
    B. Bind clot-bound thrombin
    C. Predictable effects of anticoagulation
    D. Decreased bleeding compared to heparin
    Explanation
    A key point here is that direct thrombin inhibitors can get into clots and exert an effect on thrombin. In general, the direct thrombin inhibitors bivalirudin and argatroban are a good alternative to heparin or a glycoprotein IIb/IIIa inhibitor for PCI management.

    Rate this question:

  • 17. 

    True or false: fondaparinux (Arixtra) requires antithrombin to inhibit Factor Xa

    • A.

      True

    • B.

      False

    Correct Answer
    A. True
    Explanation
    This is true; fondaparinux requires antithrombin in order to inhibit Factor Xa; this inhibition results in less conversion of prothrombin to thrombin and less conversion of fibrinogen to fibrin.

    Rate this question:

  • 18. 

    Which of the following plays a role in the dosing of fondaparinux? Check all that apply.

    • A.

      Weight

    • B.

      Indication

    • C.

      Renal function

    • D.

      Prior use of fondaparinux

    Correct Answer(s)
    A. Weight
    B. Indication
    C. Renal function
    Explanation
    Weight is used to determine the dose for treatment of VTE; for prophylaxis dosing, a weight less than 50kg results in the contraindication of fondaparinux. Indication (prophylaxis vs treatment) determines the dosing choices, which are then based on weight for treatment. Renal function is not used to determine dosing, but plays a role in that a CrCl of less than 30ml/min results in the contraindication of fondaparinux. As far as I know, prior use of fondaparinux does not affect its use.

    Rate this question:

  • 19. 

    Which of the following affect the dosing of apixaban (Eliquis)?

    • A.

      Age

    • B.

      Body weight

    • C.

      Serum creatinine

    • D.

      CYP 3A4 or P-gp inhibitors

    Correct Answer(s)
    A. Age
    B. Body weight
    C. Serum creatinine
    D. CYP 3A4 or P-gp inhibitors
    Explanation
    While the usual dose of apixaban for non-valvular atrial fibrillation is 5 mg PO BID, if the patient has 2 of the following (age > 80, body weight 1.5mg/dL), then the dose should be 2.5 mg PO BID. If a patient is on a CYP 3A4 or P-gp inhibitor, then the dose should be 2.5 mg PO BID. If the patient is on the CYP 3A4/P-gp inhibitor and is eligible for the 2.5mg PO BID dosing due to their age, weight, or serum creatinine, then the patient cannot take apixaban.

    Rate this question:

  • 20. 

    True or false: fibrinolytics only work on fibrin to bust a clot.

    • A.

      True

    • B.

      False

    Correct Answer
    B. False
    Explanation
    Fibrinolytics are also know as tissue plasminogen activators, and as such they activate plasminogen to plasmin, which then breaks up fibrin, but also breaks down fibrinogen, thus preventing more fibrin from forming. However, tPA is more specific for clot-bound fibrin than for fibrinogen. Breaking down too much circulating fibrinogen could lead to systemic fibrinolysis, which would not be good.

    Rate this question:

  • 21. 

    True or false: streptokinase is a direct tissue plasminogen activator?

    • A.

      True

    • B.

      False

    Correct Answer
    B. False
    Explanation
    Streptokinase is less specific than tPA for clot-bound fibrin, and thus binds equally to circulating and the clot-bound plasminogen, resulting in more systemic bleeding. Therefore, tPA is preferred over streptokinase for dissolving coronary and cerebral vascular thrombi. Fun fact: streptokinase is derived from streptococci (the bacteria), so patients with a recent strep infection will need a higher dose!

    Rate this question:

  • 22. 

    To change the INR due to therapy with warfarin by 1.0, change the WEEKLY dose by how much?

    • A.

      5-10%

    • B.

      10-15%

    • C.

      15-20%

    • D.

      20-25%

    Correct Answer
    B. 10-15%
    Explanation
    While there are many nomograms and tools for dosing warfarin, this is a rule of thumb for adjusting warfarin doses.

    Rate this question:

Quiz Review Timeline +

Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.

  • Current Version
  • Mar 22, 2023
    Quiz Edited by
    ProProfs Editorial Team
  • Jul 15, 2014
    Quiz Created by
    NeilTurco
Back to Top Back to top
Advertisement
×

Wait!
Here's an interesting quiz for you.

We have other quizzes matching your interest.